Metropolitan Life Insurance Company (MetLife)’s Axonics, Inc. Common Stock AXNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,615
| Closed | -$180K | – | 2235 |
|
|
2024
Q1 | $180K | Sell |
2,615
-212
| -7% | -$14.6K | 0.01% | 761 |
|
|
2023
Q4 | $176K | Hold |
2,827
| – | – | 0.01% | 794 |
|
|
2023
Q3 | $159K | Buy |
2,827
+108
| +4% | +$6.06K | 0.01% | 784 |
|
|
2023
Q2 | $137K | Hold |
2,719
| – | – | 0.01% | 863 |
|
|
2023
Q1 | $148K | Sell |
2,719
-401
| -13% | -$21.9K | 0.01% | 793 |
|
|
2022
Q4 | $195K | Buy |
3,120
+175
| +6% | +$10.9K | 0.01% | 725 |
|
|
2022
Q3 | $207K | Buy |
2,945
+163
| +6% | +$11.5K | 0.01% | 664 |
|
|
2022
Q2 | $158K | Sell |
2,782
-195
| -7% | -$11.1K | 0.01% | 818 |
|
|
2022
Q1 | $186K | Sell |
2,977
-8,782
| -75% | -$550K | 0.01% | 850 |
|
|
2021
Q4 | $659K | Hold |
11,759
| – | – | 0.01% | 1242 |
|
|
2021
Q3 | $765K | Buy |
11,759
+265
| +2% | +$17.2K | 0.01% | 1154 |
|
|
2021
Q2 | $729K | Buy |
11,494
+2,296
| +25% | +$146K | 0.01% | 1251 |
|
|
2021
Q1 | $551K | Sell |
9,198
-325
| -3% | -$19.5K | 0.01% | 1358 |
|
|
2020
Q4 | $475K | Hold |
9,523
| – | – | 0.01% | 1385 |
|
|
2020
Q3 | $486K | Hold |
9,523
| – | – | 0.01% | 1235 |
|
|
2020
Q2 | $334K | Buy |
9,523
+4,121
| +76% | +$145K | 0.01% | 1480 |
|
|
2020
Q1 | $137K | Hold |
5,402
| – | – | ﹤0.01% | 1830 |
|
|
2019
Q4 | $150K | Hold |
5,402
| – | – | ﹤0.01% | 2099 |
|
|
2019
Q3 | $145K | Buy |
5,402
+4,224
| +359% | +$114K | ﹤0.01% | 2094 |
|
|
2019
Q2 | $48.3K | Buy |
+1,178
| New | +$48.3K | ﹤0.01% | 2507 |
|